Join us for an exclusive investor webinar where Acesis Biomed will present its vision for the future of testosterone therapy.
Join us for an exclusive investor webinar where Acesis Biomed will present its vision for the future of testosterone therapy.
Traditional testosterone replacement therapies rely on synthetic hormones that can disrupt the body’s natural systems and carry long-term risks.
This webinar will offer insight into the unmet medical need, the size and scale of the opportunity, and how Acesis is uniquely positioned to lead the next chapter of innovation in hormone health and beyond.
Our leadership team will walk through the investment opportunity, highlighting the urgent need for innovation in hormone health and how our non-steroidal, oral therapy is positioned to disrupt the market.
“Product innovation is driving the testosterone therapy market with Acesis BioMed developing a non-steroidal oral peptide designed to naturally stimulate testosterone production, offering a potentially safer alternative to traditional treatments”
The discoveries by Dr. Papadopoulos, a world-renowned expert in steroid biochemistry with 35+ years of experience, has resulted in a novel mechanism of action that restores the body’s natural ability to produce testosterone (based on our current preclinical data)—a breakthrough protected by two patent families owned by Acesis.
The discoveries by Dr. Papadopoulos, a world-renowned expert in steroid biochemistry with 35+ years of experience, has resulted in a novel mechanism of action that restores the body’s natural ability to produce testosterone (based on our current preclinical data)—a breakthrough protected by two patent families owned by Acesis.
©2025 Acesis Biomed. All rights reserved.